About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
MF HOLDINGS
MF
Holdings
Astrazeneca Pharma India Ltd.
BSE Code
506820
ISIN Demat
INE203A01020
Book Value
271.74
NSE Code
ASTRAZEN
Dividend Yield %
0.37
Market Cap
162421.25
P/E
198.27
EPS
32.77
Face Value
2
Scheme Name
Market Val (In Crs.)
AUM(In Crs.)
Hold Percentage
Nippon India Small Cap Fund(G)
524.49
62259.55
0.84
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
107.09
4987.49
2.15
ICICI Pru Smallcap Fund(G)
98.92
8824.91
1.12
ICICI Pru Innovation Fund-Reg(G)
78.16
6653.79
1.17
Nippon India Pharma Fund(G)
51.07
8768.67
0.58
Bandhan Innovation Fund-Reg(G)
48.95
1251.63
3.91
Bandhan Small Cap Fund-Reg(G)
36.88
8489.25
0.43
Bandhan Hybrid Equity Fund-Reg(G)
12.91
817.5
1.58
Nippon India Nifty Smallcap 250 Index Fund-Reg(G)
4.60
1873.67
0.25
SBI Nifty Smallcap 250 Index Fund-Reg(G)
2.85
1160.93
0.25
WOC Pharma and Healthcare Fund-Reg(G)
2.66
200.07
1.33
Motilal Oswal Nifty Smallcap 250 Index Fund-Reg(G)
2.04
828.81
0.25
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF
2.01
356.93
0.56
HDFC NIFTY Smallcap 250 ETF
1.29
529.99
0.24
ICICI Pru Nifty Smallcap 250 Index Fund(G)
1.03
427.51
0.24
HDFC NIFTY Smallcap 250 Index Fund-Reg(G)
0.81
326.9
0.25
Mirae Asset Nifty MidSmallcap400 Momentum Quality 100 ETF
0.74
270.65
0.27
Motilal Oswal Nifty 500 Index Fund-Reg(G)
0.52
2102.99
0.02
Motilal Oswal Nifty Smallcap 250 ETF
0.25
102.43
0.25
Groww Nifty Smallcap 250 Index Fund-Reg(G)
0.22
88.22
0.24
Page
1
of
2
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.